Literature DB >> 31056802

Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses.

Irina Midenfjord1, Annikka Polster1, Henrik Sjövall1, Hans Törnblom1, Magnus Simrén1,2.   

Abstract

BACKGROUND: Anxiety or depression, in other words, psychological distress, are common comorbidities in patients with irritable bowel syndrome (IBS), but their interaction with pathophysiological factors and other symptoms are unclear.
METHODS: Patients with IBS (Rome III criteria), thoroughly characterized regarding pathophysiology (colonic transit time, visceral sensitivity, and autonomic nervous system [ANS] function), symptom profile (IBS severity, somatic symptoms, gastrointestinal [GI]-specific anxiety and fatigue), and quality of life, were explored for differences regarding pathophysiology and symptoms between patients with and without reported psychological distress in univariate and multivariate analyses (Principal Component Analysis [PCA] with Hotelling's T2 and Orthogonal Partial Least Squares-Discriminant Analysis [OPLS-DA]). KEY
RESULTS: When using Hospital Anxiety and Depression Scale score ≥8 as cut-off score, including both borderline and clinically significant cases, 345 (44.9%) out of 769 IBS patients reported anxiety, and 198 (25.7%) depression. In univariate analyses, patients reporting psychological distress demonstrated more severe GI and non-GI symptoms, fatigue, GI-specific anxiety and lower quality of life, and differences for some pathophysiological measures. IBS patients with and without reported psychological distress showed significant differences between the multivariate means in symptom reporting (PCA; both P < 0.001), and in pathophysiological measures in patients with and without anxiety (P = 0.018). Visceral hypersensitivity, altered ANS function, more severe GI-specific anxiety, fatigue, and higher somatic non-GI symptoms were the factors that most strongly separated patients with and without psychological distress (OPLS-DA). CONCLUSIONS AND INFERENCES: Reported anxiety and depression are common in IBS patients, and our study demonstrates that they are interwoven in the complex pathophysiological and clinical picture of IBS.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  anxiety; depression; irritable bowel syndrome; multivariate analysis

Mesh:

Year:  2019        PMID: 31056802     DOI: 10.1111/nmo.13619

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  20 in total

1.  Impact of COVID-19 on Individuals With Irritable Bowel Syndrome and Comorbid Anxiety and/or Depression.

Authors:  Kendra J Kamp; Rona L Levy; Sean A Munson; Margaret M Heitkemper
Journal:  J Clin Gastroenterol       Date:  2022-02-01       Impact factor: 3.062

2.  Dynorphin participates in interaction between depression and non-erosive reflux disease.

Authors:  Yi Wang; Bingduo Zhou; Shengquan Fang; Shengliang Zhu; Tingting Xu; Makan Dilikumaer; Guanwu Li
Journal:  Esophagus       Date:  2022-10-16       Impact factor: 3.671

3.  Global Research Trends in Irritable Bowel Syndrome: A Bibliometric and Visualized Study.

Authors:  Tai Zhang; Xiangxue Ma; Wende Tian; Jiaqi Zhang; Yuchen Wei; Beihua Zhang; Fengyun Wang; Xudong Tang
Journal:  Front Med (Lausanne)       Date:  2022-06-27

Review 4.  Dietary Fibre Intervention for Gut Microbiota, Sleep, and Mental Health in Adults with Irritable Bowel Syndrome: A Scoping Review.

Authors:  Ran Yan; Lesley Andrew; Evania Marlow; Kanita Kunaratnam; Amanda Devine; Ian C Dunican; Claus T Christophersen
Journal:  Nutrients       Date:  2021-06-23       Impact factor: 5.717

Review 5.  The gut microbiome and neuropsychiatric disorders: implications for attention deficit hyperactivity disorder (ADHD).

Authors:  Kalai Mathee; Trevor Cickovski; Alok Deoraj; Melanie Stollstorff; Giri Narasimhan
Journal:  J Med Microbiol       Date:  2020-01       Impact factor: 2.472

6.  Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome.

Authors:  Gerardo Calderon; Chirag Patel; Michael Camilleri; Toyia James-Stevenson; Matthew Bohm; Robert Siwiec; Nicholas Rogers; John Wo; Carolyn Lockett; Anita Gupta; Huiping Xu; Andrea Shin
Journal:  J Clin Gastroenterol       Date:  2022-03-01       Impact factor: 3.062

Review 7.  Sex- and Gender-Related Differences in Common Functional Gastroenterologic Disorders.

Authors:  Susrutha Puthanmadhom Narayanan; Bradley Anderson; Adil E Bharucha
Journal:  Mayo Clin Proc       Date:  2021-04       Impact factor: 7.616

Review 8.  Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis.

Authors:  Hannibal Person; Laurie Keefer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-12-14       Impact factor: 5.067

Review 9.  The Role of Epigenomic Regulatory Pathways in the Gut-Brain Axis and Visceral Hyperalgesia.

Authors:  Gerald A Higgins; Shaungsong Hong; John W Wiley
Journal:  Cell Mol Neurobiol       Date:  2021-05-31       Impact factor: 5.046

10.  Associations of Abdominal Pain and Psychosocial Distress Measures With Health-Related Quality-of-Life in Pediatric Healthy Controls and Irritable Bowel Syndrome.

Authors:  John M Hollier; Danita I Czyzewski; Mariella M Self; Yan Liu; Erica M Weidler; Miranda A L van Tilburg; James W Varni; Robert J Shulman
Journal:  J Clin Gastroenterol       Date:  2021 May-Jun 01       Impact factor: 3.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.